Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome
T Iwaniec, MP Kaczor, M Celińska-Löwenhoff… - Thrombosis …, 2017 - Elsevier
Background Antiphospholipid syndrome (APS) is characterized by the presence of
circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy …
circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy …
[HTML][HTML] Role of anti‐domain 1‐β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome
AS De Craemer, J Musial, KMJ Devreese - Journal of thrombosis and …, 2016 - Elsevier
Essentials• Antibodies to domain 1 of β 2 glycoprotein I (aD1) are a subset of
antiphospholipid antibodies.• We evaluated the added diagnostic value of an automated …
antiphospholipid antibodies.• We evaluated the added diagnostic value of an automated …
The significance of antibodies against domain I of beta-2 glycoprotein I in antiphospholipid syndrome
H Kelchtermans, W Chayouâ… - Seminars in thrombosis …, 2018 - thieme-connect.com
The antiphospholipid syndrome (APS) is characterized by vascular thrombosis and/or
pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPLs) …
pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPLs) …
The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study
B De Laat, V Pengo, I Pabinger, J Musial… - … of thrombosis and …, 2009 - Wiley Online Library
Background: Diagnosis of the antiphospholipid syndrome (APS) is difficult as a result of
limited specificity of existing assays for detecting clinically relevant antiphospholipid …
limited specificity of existing assays for detecting clinically relevant antiphospholipid …
[HTML][HTML] The (non‐) sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
W Chayoua, H Kelchtermans, JC Gris… - Journal of Thrombosis …, 2020 - Elsevier
Background The antiphospholipid syndrome (APS) is characterized by thrombosis and/or
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …
pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti …
Laboratory testing for non-criteria antiphospholipid antibodies: antibodies toward the domain I of beta2-glycoprotein I (aDI)
KMJ Devreese - Hemostasis and Thrombosis: Methods and Protocols, 2023 - Springer
Anti-β2GPI antibodies (aβ2GPI) are one of the laboratory criteria for antiphospholipid
syndrome (APS), along with lupus anticoagulant (LA) and anticardiolipin antibodies (aCL). A …
syndrome (APS), along with lupus anticoagulant (LA) and anticardiolipin antibodies (aCL). A …
Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis
R Li, M Daguzan, F Vandermijnsbrugge… - Acta Clinica …, 2014 - Taylor & Francis
Objectives: The aim of our study was to evaluate the clinical values of anti-beta2
glycoprotein I antibodies (anti-beta2GPI) IgG and IgM comparing with lupus anticoagulant …
glycoprotein I antibodies (anti-beta2GPI) IgG and IgM comparing with lupus anticoagulant …
Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
R Mondejar, C González-Rodríguez, FJTS De Miera… - Clinica Chimica …, 2014 - Elsevier
Background Antiphospholipid syndrome (APS) is characterized by the presence circulating
antiphospholipid (aPL) antibodies in patients with thrombosis or pregnancy morbidity …
antiphospholipid (aPL) antibodies in patients with thrombosis or pregnancy morbidity …
[HTML][HTML] High‐avidity anti‐β2 glycoprotein I antibodies highly correlate with thrombosis in contrast to low‐avidity anti‐β2 glycoprotein I antibodies
B De Laat, R Derksen, PG De Groot - Journal of Thrombosis and …, 2006 - jthjournal.org
© 2006 International Society on Thrombosis and Haemostasis coagulation assays (lupus
anti-coagulant;, LAC), or by two solid phase immune assays, the anti-cardiolipin ELISA and …
anti-coagulant;, LAC), or by two solid phase immune assays, the anti-cardiolipin ELISA and …
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study
M Tonello, E Mattia, T Del Ross, M Favaro… - Clinica Chimica …, 2018 - Elsevier
Background There seems to be a clear correlation between antibodies against domain I
(anti-DI) of β2Glycoprotein I and severe clinical profiles in antiphospholipid syndrome (APS) …
(anti-DI) of β2Glycoprotein I and severe clinical profiles in antiphospholipid syndrome (APS) …
相关搜索
- anti β2glycoprotein antiphospholipid syndrome
- significance of antibodies antiphospholipid syndrome
- β2 glycoprotein antiphospholipid syndrome
- β2 glycoprotein clinical significance
- anti domain antibodies in the diagnosis
- significance of antibodies beta 2
- clinical relevance antiphospholipid syndrome
- anti domain risk stratification
- beta 2 antiphospholipid syndrome
- risk stratification antiphospholipid syndrome
- beta2 glycoprotein circulating antibodies
- plasma levels antiphospholipid syndrome
- anti β2glycoprotein non sense
- non sense antiphospholipid syndrome
- anti domain antiphospholipid syndrome
- clinical significance antiphospholipid syndrome